Virtual Journal Club

Please note: This website is for discussion purposes only. The information provided at this website is not intended to provide treatment advice, or to diagnose or treat any medical disorder. The creator of this website is not responsible for events that occur as a result of decisions made based on the information presented here.

Citations powered by PubMed

Entries Tagged as 'Am J Health Syst Pharm'

Impact of atrial fibrillation and oral anticoagulation on hospital costs and length of stay.

February 4th, 2012 · Start a Discussion

Impact of atrial fibrillation and oral anticoagulation on hospital costs and length of st…

[Read more →]

Tags: Am J Health Syst Pharm

Comparison of rates of reported adverse events associated with i.v. iron products in the United States.

February 4th, 2012 · Start a Discussion

Comparison of rates of reported adverse events associated with i.v. iron products in the …

[Read more →]

Tags: Am J Health Syst Pharm

Development and implementation of a comprehensive heparin-induced thrombocytopenia recognition and management protocol.

January 21st, 2012 · Start a Discussion

Development and implementation of a comprehensive heparin-induced thrombocytopenia recogn…

[Read more →]

Tags: Am J Health Syst Pharm

Aztreonam lysine for inhalation: New formulation of an old antibiotic.

January 5th, 2012 · Start a Discussion

Aztreonam lysine for inhalation: New formulation of an old antibiotic.
Am J Healt…

[Read more →]

Tags: Am J Health Syst Pharm

Inpatient warfarin: Experience with a pharmacist-led anticoagulation management service in a tertiary care medical center.

December 20th, 2011 · Start a Discussion

Inpatient warfarin: Experience with a pharmacist-led anticoagulation management service i…

[Read more →]

Tags: Am J Health Syst Pharm

New treatment options for acute edema attacks caused by hereditary angioedema.

November 8th, 2011 · Start a Discussion

New treatment options for acute edema attacks caused by hereditary angioedema.
Am…

[Read more →]

Tags: Am J Health Syst Pharm

Improving adherence to best-practice guidelines for venous thromboembolism risk assessment and prevention.

November 8th, 2011 · Start a Discussion

Improving adherence to best-practice guidelines for venous thromboembolism risk assessmen…

[Read more →]

Tags: Am J Health Syst Pharm

Improving adherence to best-practice guidelines for venous thromboembolism risk assessment and prevention.

November 8th, 2011 · Start a Discussion

Improving adherence to best-practice guidelines for venous thromboembolism risk assessmen…

[Read more →]

Tags: Am J Health Syst Pharm

Implementation of an inpatient anticoagulation teaching service: Expanding the role of pharmacy students and residents in patient education.

November 1st, 2011 · Start a Discussion

Implementation of an inpatient anticoagulation teaching service: Expanding the role of ph…

[Read more →]

Tags: Am J Health Syst Pharm

Drug-induced heart failure.

September 25th, 2011 · Start a Discussion

Drug-induced heart failure.
Am J Health Syst Pharm. 2011 Oct 1;68(19):1791-804
Authors: Maxwell CB, Jenkins AT
Abstract
Purpose The published evidence on the role of various drugs and medication classes in caus…

[Read more →]

Tags: Am J Health Syst Pharm

Effect of fondaparinux prophylaxis on anti-factor Xa concentrations in patients with morbid obesity.

September 2nd, 2011 · Start a Discussion

Effect of fondaparinux prophylaxis on anti-factor Xa concentrations in patients with morbid obesity.
Am J Health Syst Pharm. 2011 Sep 15;68(18):1716-22
Authors: Martinez L, Burnett A, Borrego M, Streeter JC, Townsend K, Garcia…

[Read more →]

Tags: Am J Health Syst Pharm

Development and implementation of an interdisciplinary oncology program in a community hospital.

September 2nd, 2011 · Start a Discussion

Development and implementation of an interdisciplinary oncology program in a community hospital.
Am J Health Syst Pharm. 2011 Sep 15;68(18):1740-7
Authors: Chung C, Collins A, Cui N
Abstract
Purpose The develop…

[Read more →]

Tags: Am J Health Syst Pharm

Dabigatran etexilate: A novel oral direct thrombin inhibitor.

August 8th, 2011 · Start a Discussion

Dabigatran etexilate: A novel oral direct thrombin inhibitor.
Am J Health Syst Pharm. 2011 Aug 15;68(16):1506-19
Authors: Blommel ML, Blommel AL
Purpose The pharmacology, pharmacokinetics, clinical efficacy, tolerabili…

[Read more →]

Tags: Am J Health Syst Pharm

Anticoagulation therapy for hospitalized patients: Patterns of use, compliance with national guidelines, and performance on quality measures.

June 24th, 2011 · Start a Discussion

Anticoagulation therapy for hospitalized patients: Patterns of use, compliance with national guidelines, and performance on quality measures.
Am J Health Syst Pharm. 2011 Jul 1;68(13):1239-44
Authors: Tiryaki F, Nutescu EA, He…

[Read more →]

Tags: Am J Health Syst Pharm

Management of HIV infection in treatment-naive patients: A review of the most current recommendations.

May 20th, 2011 · Start a Discussion

Management of HIV infection in treatment-naive patients: A review of the most current recommendations.
Am J Health Syst Pharm. 2011 Jun 1;68(11):991-1001
Authors: Boyd SD
Purpose The most current guidelines issued by t…

[Read more →]

Tags: Am J Health Syst Pharm